Contact Information

37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG

We Are Available 24/ 7. Call Now.
The Company That Defined Dieting Is Sorry It Told Us to Have More Willpower
Business

The Company That Defined Dieting Is Sorry It Told Us to Have More Willpower

Ozempic, Oprah and apologies: WeightWatchers says there’s no shame in being overweight, or in taking new weight-loss drugs. Source link

To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit-Card Debts
Business

To Pay for Weight Loss Drugs, Some Take Second Jobs, Ring Up Credit-Card Debts

Some people are paying more than $10,000 a year for Ozempic and Mounjaro. Source link

Employers Cut Off Access to Weight-Loss Drugs for Workers
Business

Employers Cut Off Access to Weight-Loss Drugs for Workers

Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to save money. Source link

The Hidden Career Cost of Being Overweight
Business

The Hidden Career Cost of Being Overweight

New moves to outlaw weight discrimination are pushing companies to examine one of the most insidious forms of on-the-job bias. Source link

Noom Picks Veteran Tech Executive as CEO
Business

Noom Picks Veteran Tech Executive as CEO

Geoff Cook would manage the digital-health platform as the company looks to seize on surging interest in weight-loss treatments. Source link

Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.
Business

Drugs Like Ozempic Created a Gold Rush. These Drugmakers Want In.

Companies developing weight-loss drugs have raised or made deals valued at more than $1.4 billion since about a year ago. Source link

Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts
Business

Europe Is Probing Whether Ozempic Use Raises Risk of Suicidal Thoughts

Ozempic is under review by European drug-safety regulators after they received reports of suicidal thoughts linked to the popular weight-loss drug and another medicine in

Obesity Drugs Won't Starve These Other Potential Blockbusters
Finances

Obesity Drugs Won't Starve These Other Potential Blockbusters

Stocks of developers of fatty liver disease treatments had been on a tear until results from Eli Lilly’s medication were published last week. Source link

Demand for Obesity Drugs Has Insurers Paying Close Attention
Finances

Demand for Obesity Drugs Has Insurers Paying Close Attention

Markets Heard on the Street Strong sales of obesity-diabetes drugs known as GLP-1s could affect insurance companies’ financial results Source link

UnitedHealth First-Quarter Earnings, Revenue Up as Company Added Members
Business

UnitedHealth First-Quarter Earnings, Revenue Up as Company Added Members

Business Earnings Company sees moderate health spending, but higher costs for drugs such as Ozempic Source link